Conference Series LLC, DoubleTree by Hilton Beijing
08/10/2017
Biosimilars Asia 2017 is a specially designed cluster conference. The main theme of the conference is "Biosimilars-Uncovering An Innovation In Motion" which covers a wide range of critically important sessions. All over the world, there are more than 380 companies producing Biologics and Biosimilars and 55,000 industrialists doing their research work. The global Biosimilars market (Follow-On-Biologics) is expected to reach $26.5Billion by 2020 growing at a CAGR of 49.1% from 2015 to 2020 whereas the global biosimilars market alone is expected to reach $6.22 Billion by 2020 from $2.29 Billion in 2015, at a compound annual growth rate (CAGR) of 22.1% from 2015 to 2020. There are currently more biosimilar products in development across the Asia-Pacific region than anywhere else in the world, leading to a wealth of opportunities for investigators and patients to take part in biosimilar clinical trials. Countries in Asia, particularly India, Singapore, Korea, Japan and China, are the attractive locations to build bio development and bio manufacturing capabilities.
|
|